Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma

被引：0
|
作者：
Romancik, Jason T.
Allen, Pamela B.
Waller, Edmund K.
Chen, Zhengjia
Valla, Kelly
Dixon, Kaylan
Reagan, David J.
Colbert, Amanda B.
Rosand, Cecilia
Palmer, Alexandra
Flowers, Christopher
Cohen, Jonathon B.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Autologous stem-cell transplant plus rituximab for newly diagnosed mantle cell lymphoma: Up-date of a phase II trial
    Hicks, L
    Mangel, J
    Connors, J
    Buckstein, R
    Leitch, H
    Imrie, K
    Crump, M
    Spaner, D
    Pennell, N
    Nagy, T
    Boudreau, A
    Berinstein, N
    ANNALS OF ONCOLOGY, 2005, 16 : 170 - 170
  • [32] Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle Trial
    Villa, Diego
    Larouche, Jean-Francois
    Cheung, Matthew C.
    Keating, Mary-Margaret
    Zukotynski, Katherine
    Tonseth, Petter
    Mayo, Samantha
    Laister, Robert
    Scott, David W.
    Kuruvilla, John
    BLOOD, 2023, 142
  • [33] Autologous stem cell transplantation and Rituximab independently prolong response duration in advanced stage mantle cell lymphoma
    Hoster, E.
    Metzner, B.
    Pfreundschuh, M.
    Truemper, L.
    Hallek, M.
    Woermann, B.
    Duehrsen, U.
    Gisselbracht, C.
    Kluin-Nelemans, J. C.
    Van Hoof, A.
    Unterhalt, M.
    Hiddemann, W.
    Dreyling, M.
    ONKOLOGIE, 2010, 33 : 202 - 202
  • [34] Maintenance Rituximab after High-Dose Therapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
    Roider, Tobias
    Dietrich, Sascha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) : 1811 - 1812
  • [35] Rituximab Maintenance Therapy after Autologous Stem Cell Transplantation Improves Survival of Patients with Mantle Cell Lymphoma
    Graf, Solomon A.
    Stevenson, Philip A.
    Holmberg, Leona A.
    Till, Brian G.
    Press, Oliver W.
    Chauncey, Thomas R.
    Smith, Stephen D.
    Philip, Mary
    Orozco, Johnnie J.
    Shustov, Andrei R.
    Green, Damian J.
    Libby, Edward N.
    Bensinger, William I.
    Pagel, John M.
    Maloney, David G.
    Zhou, Yi
    Cassaday, Ryan D.
    Gopal, Ajay K.
    BLOOD, 2014, 124 (21)
  • [36] Rituximab improves the outcome of upfront autologous stem cell transplantation in mantle cell lymphoma: A comparison of different strategies
    Rieger, Michael
    Witzens-Harig, Mathias
    Hensel, Manfred
    Seyfarth, Baerbel
    Nickelsen, Maike
    Kneba, Michael
    Schmitz, Norbert
    Ho, Anthony D.
    Dreger, Peter
    BLOOD, 2007, 110 (11) : 358B - 358B
  • [37] The Prognostic Value of FDG PET/CT Prior to Autologous Stem Cell Transplant in Mantle Cell Lymphoma
    Cohen, Jonathon B.
    Hall, Nathan
    Ruppert, Amy S.
    Jones, Jeffrey A.
    Porcu, Pierluigi
    Baiocchi, Robert A.
    Penza, Sam
    Benson, Don M., Jr.
    Andritsos, Leslie A.
    Flynn, Joseph M.
    Devine, Steven M.
    Blum, Kristie A.
    BLOOD, 2011, 118 (21) : 1345 - 1346
  • [38] Rituximab in autologous stem cell transplantation for follicular lymphoma
    Schmitz, N
    ANTI-CANCER DRUGS, 2001, 12 : S21 - S24
  • [39] Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma
    Kasamon, Y. L.
    Jones, R. J.
    Brodsky, R. A.
    Fuchs, E. J.
    Matsui, W.
    Luznik, L.
    Powell, J. D.
    Blackford, A. L.
    Goodrich, A.
    Gocke, C. D.
    Abrams, R. A.
    Ambinder, R. F.
    Flinn, I. W.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1203 - 1210
  • [40] Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as 'in vivo purge' and consolidative immunotherapy following autologous stem cell transplantation
    Mangel, J
    Buckstein, R
    Imrie, K
    Spaner, D
    Franssen, E
    Pavlin, P
    Boudreau, A
    Pennell, N
    Combs, D
    Berinstein, NL
    ANNALS OF ONCOLOGY, 2003, 14 (05) : 758 - 765
12345